Abbott India (Abbott) continues to fare better than its MNC peers who are struggling for growth in line with the market rate for last couple of quarters. In Q1FY24, Abbott grew 13.4% ahead of the market growth of 9% despite mandated price cut on NLEM products (26% of core portfolio sales).